Literature DB >> 20677539

Nephrogenic systemic fibrosis: a review.

Amy Y-Y Chen1, Matthew J Zirwas, Michael P Heffernan.   

Abstract

Nephrogenic systemic fibrosis (NSF) is a recently described, debilitating systemic disease most commonly seen in patients with renal insufficiency. Exposure to gadolinium-containing contrast agent has been associated with the onset of symptoms. The epidemiology, pathogenesis, clinical manifestation, diagnosis, histolopathology, differential diagnosis and treatment will be reviewed. Clinicians should have a high index of suspicion in susceptible individuals.

Entities:  

Mesh:

Year:  2010        PMID: 20677539

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  5 in total

1.  Manganese-based MRI contrast agents: past, present and future.

Authors:  Dipanjan Pan; Anne H Schmieder; Samuel A Wickline; Gregory M Lanza
Journal:  Tetrahedron       Date:  2011-11-04       Impact factor: 2.457

2.  A novel role of vimentin filaments: binding and stabilization of collagen mRNAs.

Authors:  Azariyas A Challa; Branko Stefanovic
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

3.  A moderate response to plasmapheresis in nephrogenic systemic fibrosis.

Authors:  Pelin Ustuner; Ozlem Karadag Kose; A Tulin Gulec; Ozlem Ozen
Journal:  Clin Pract       Date:  2011-11-29

4.  Safety and efficacy of gadobutrol-enhanced MRI in patients aged under 2 years-a single-center, observational study.

Authors:  Ravi Bhargava; Michelle Noga
Journal:  Magn Reson Insights       Date:  2013-02-06

5.  Role of LARP6 and nonmuscle myosin in partitioning of collagen mRNAs to the ER membrane.

Authors:  Hao Wang; Branko Stefanovic
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.